Founded in 1985 by MIT- and Harvard-trained scientist Dr. Dean Hsieh, Conrex Pharmaceutical develops transdermal drug-delivery technology and therapeutic formulations. The company is best known for Permeation Enhancement Technology™ (PET™), its patented polymer-matrix system for temporarily helping larger active molecules pass through the skin, a platform used in the FDA-approved Testim® testosterone gel and in Conrex’s SESHA Skin Therapy line. After Dr. Hsieh’s death in 1995, his wife and co-founder, Phyllis Hsieh, became president and CEO and guided the company’s expansion into skincare.
FDA GRAS (Generally Recognized as Safe)
Compliance program
Drug Master File with FDA
Registration